Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
Michael Trogdon(Salk Institute for Biological Studies), Edward C. Stites(Salk Institute for Biological Studies)
Cited by 3
Related Papers
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
|npj Precision Oncology|2022|16